Longitudinal Study of Salivary Biomarkers in the Definition of Clinico‐Molecular Progression of Parkinson's Disease
Salivary biomarkers dynamically reflect PD progression and predict long-term clinical outcomes. These findings support the use of saliva as a noninvasive, accessible source for predicting and monitoring disease progression in PD.
Authors
- Daniele Belvisi (ORCID: https://orcid.org/0000-0001-8681-3050)
- Giovanni Fabbrini (ORCID: https://orcid.org/0000-0001-7614-8771)
- Massimo Marano (ORCID: https://orcid.org/0000-0001-9885-3666)
- Romina Mancinelli (ORCID: https://orcid.org/0000-0003-2040-0581)
- Antonella Conte (ORCID: https://orcid.org/0000-0002-6338-2961)
- Alfredo Berardelli (ORCID: https://orcid.org/0000-0003-3598-3142)
- Carolina Cutrona
- Giorgio Vivacqua (ORCID: https://orcid.org/0000-0001-6080-7007)
- Giorgio Leodori (ORCID: https://orcid.org/0000-0002-6631-6740)
- Matteo Costanzo (ORCID: https://orcid.org/0000-0002-4369-014X)
- Maria Ilenia De Bartolo (ORCID: https://orcid.org/0000-0002-8747-9805)
- Claudia Caturano
- Francesco Emanuele Bellomi
- Flavia Aiello
Institutions
- Università Campus Bio-Medico (IT)
- Istituto Superiore di Sanità (IT)
- Azienda Ospedaliera San Giovanni Addolorata (IT)
- Policlinico Umberto I (IT)
- Istituto Neurologico Mediterraneo (IT)
- Policlinico Tor Vergata (IT)
- Campus Bio Medico University Hospital (IT)
- Sapienza University of Rome (IT)
Publication Details
- Journal
- Annals of Clinical and Translational Neurology
- Published
- 2025-09-27
- DOI
- https://doi.org/10.1002/acn3.70178
- Primary Topic
- Parkinson's Disease Mechanisms and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00